INTRODUCTION
============

Seed size is an important agronomic trait that influences many aspects of regeneration strategies, such as seedling growth, survival rate, and seed dispersal syndrome ([@b37-molce-41-12-1072]). Seed development begins with double fertilization, followed by differentiation of seed coat derived from the integuments ([@b18-molce-41-12-1072]). Once double fertilization succeeds in flowering plants, endosperm development proceeds through syncytium formation, followed by cellularization and differentiation ([@b17-molce-41-12-1072]). The embryo then grows from the endosperm, utilizing nutrients and occupying most of the mature seed. During this period, the integument, which begins to form at ovule development, also undergoes cell differentiation and accumulates pigments, mucilage, and starch granules, eventually forming the mature seed coat ([@b34-molce-41-12-1072]). Therefore, successful seed development and the resulting final size of seeds are determined by the coordinated growth of the embryo, endosperm, and maternal integuments.

In *Arabidopsis*, many genes associated with seed development have been identified. *SHORT HYPOCOTYL UNDER BLUE1* (*SHB1* ), *HAIKU1* (*IKU1* ), *HAIKU2* (*IKU2* ), and *MINISEED3* (*MINI3* ) are involved in endosperm size determination and embryo development ([@b20-molce-41-12-1072]; [@b31-molce-41-12-1072]; [@b38-molce-41-12-1072]). SHB1 is a positive regulator of *MINI3* and *IKU2* expression, although it cannot directly bind to DNA sequences ([@b38-molce-41-12-1072]). *MINI3* encodes a WRKY family transcription factor and is expressed in both the endosperm and embryo; it promotes the expression of *IKU2,* which encodes a leucine-rich repeat receptor kinase in the endosperm. Therefore, SHB1, MINI3, and IKU2 form a small signaling unit that successively acts to expand the seed cavity ([@b20-molce-41-12-1072]). In addition to SHB1, IKU1 also interacts and promotes *MINI3* expression ([@b31-molce-41-12-1072]). The genes encoding MADS-box transcription factors, such as *AGAMOUS-LIKE1 61* (*AGL61*), *AGL62,* and *AGL80*, also regulate endosperm development ([@b1-molce-41-12-1072]; [@b14-molce-41-12-1072]; [@b27-molce-41-12-1072]).

Plant hormones, such as brassinosteroids (BRs), cytokinins, auxin, and abscisic acid (ABA), regulate many aspects of seed development ([@b29-molce-41-12-1072]), and their activities seem to be interrelated ([@b19-molce-41-12-1072]). ABA negatively regulates endosperm development, because the seed size of the ABA-deficient mutant *aba2* or ABA-insensitive mutant *abi5* was greater than that of the wild-type plants ([@b3-molce-41-12-1072]). In contrast, BRs promote the enlargement of seed size, because the BR-insensitive mutant *bri1-5* or BR-deficient mutant *det2-1* showed reduced seed size compared with that of the wild type ([@b12-molce-41-12-1072]). BR signaling triggered from the cell surface receptor complex BRI1/BAK1 ([@b22-molce-41-12-1072]; [@b32-molce-41-12-1072]) is transduced to the transcription factors BRASSINAZOLE-RESISTANT1 (BZR1) and BRI1-EMS-SUPPRESSOR1 (BES1) ([@b33-molce-41-12-1072]; [@b35-molce-41-12-1072]) to regulate numerous BR-responsive genes ([@b15-molce-41-12-1072]; [@b29-molce-41-12-1072]). Recently, the expression of the *SHB1*, *IKU2*, and *MINI3* was shown to be induced by BR. BZR1 directly bound to the promoters of *SHB1* and *IKU1* and activated them ([@b12-molce-41-12-1072]). SHB1 activates *MINI3* and *IKU2* expression, and IKU1 interacts with MINI3 to activate *IKU2* ([@b20-molce-41-12-1072]; [@b38-molce-41-12-1072]).

In *Arabidopsis*, 118 genes encoding plant-specific B3 transcription factors have been identified ([@b30-molce-41-12-1072]). Among them, a subset related to the ABI3/VP1 (RAV) transcription factor subfamily is encoded by six genes (*RAV1*, *RAV1L*, *TEM1*, *TEM2/RAV2*, *At1g50680,* and *At1g51120* ) and possesses the AP2-domain ([@b25-molce-41-12-1072]). RAV1 was the first transcription factor identified in this family as a novel DNA-binding protein with bipartite sequence motifs ([@b13-molce-41-12-1072]). Since then, RAV family transcription factors have been considered negative growth regulators by antisense and overexpression approaches ([@b2-molce-41-12-1072]; [@b11-molce-41-12-1072]; [@b24-molce-41-12-1072]). Previously, the growth promotion in *rav1* knockout mutant plants in the early stage of development and growth retardation in transgenic plants overexpressing *RAV1* were considered under the control of a native promoter ([@b6-molce-41-12-1072]). The expression of *RAV1* was regulated by many plant hormones and down-regulated by ABA ([@b6-molce-41-12-1072]; [@b11-molce-41-12-1072]). BR-induced repression of *RAV1* seems to be mediated by the direct binding of BZR1 to the promoter of *RAV1* ([@b10-molce-41-12-1072]; [@b29-molce-41-12-1072]).

In this study, we focused on how RAV1 affects seed development, because overexpression of the *RAV1* adversely affected all aspects, such as seed size and mass, seed numbers in a silique, and seed shape. The endogenous expression of *RAV1* remained low during the seed developmental stage. We examined the expression of the genes associated with ovule development or embryo and endosperm development in the *RAV1*-overexpressing transgenic plants. We found that the expressions of *MINI3* and *IKU2,* the two downstream genes of the *SHB1*-*MINI3*-*IKU2* cascade in the seed development pathway, were particularly reduced, because RAV1 directly binds to the promoter of *MINI3* and *IKU2*, resulting in their repression.

MATERIALS AND METHODS
=====================

Plant growth and conditions
---------------------------

*Arabidopsis thaliana* Columbia (Col-0) was used as wild type. *RAV1*-overexpressing transgenic plants in a Col-0 background were previously described ([@b6-molce-41-12-1072]). For growth in soil, seeds were planted directly onto Sunshine \#5 top-layered with fine granules of vermiculite. All plants were grown at 22°C under long-day conditions (16 of light and 8 of darkness).

Assessment of seed germination
------------------------------

Seeds were sterilized in 75% ethanol containing 0.05% Tween-20 for 15 min, washed twice with 95% ethanol, and placed onto 1/2 Murashige & Skoog (MS) (Duchefa) media containing 0.8% phytoagar. The plate was sequentially exposed to far-red light (3.2 μmol/m^2^/s) and red light (20 μmol/m^2^/s) as previously described ([@b23-molce-41-12-1072]), and then placed in the growth room set to long day conditions. Each day, germinating seeds were counted based on radicle protrusion and the germination rate was calculated.

Morphological analysis of seeds
-------------------------------

Seed morphology was analyzed for the seeds in green siliques of the *RAV1*-overexpressing transgenic plants and wild-type plants using a dissecting microscope (Leica MZ12.5 stereomicroscope). To examine the effect of direct application of BL and ABA, 2 μl of BL (1 μM) or ABA (10 μM) solution was absorbed onto the floral bud at stage 12--13. After 7 days, siliques were collected and analyzed. The number of seeds showing various defects per silique counted. Seed weight was determined by weighing 500 dry seeds at a time. Seed length and width were measured using the images that were taken using the dissecting microscope equipped with a CCD camera, and were analyzed using Image J software.

RNA expression analysis
-----------------------

Total RNA was extracted from various floral stages from 12 to 20 using TRI Reagent® (SIGMA). First-strand cDNAs were synthesized using RNA treated with RNase-free RQ1 DNases (Promega) and adding SuperScript^III^-MMLV reverse transcriptase (Invitrogen) and the Oligo(dT)-15 primer. An aliquot of the cDNA samples was used as template for quantitative RT-PCR analyses using SYBR Green PCR Master Mix in the Step-One Plus Real Time PCR system (Applied Biosystems). Expression of the *Ubiquitin* gene (*At3g62250* ) was used to normalize the data.

Chromatin immunoprecipitation (ChIP) assay
------------------------------------------

The ChIP assay was performed following the procedure previously described ([@b9-molce-41-12-1072]) with some modifications. In brief, 0.8 g of floral tissue at stages 15 to 16 from the *RAV1*-overexpressing transgenic plants were cross-linked with 1% formaldehyde for 15 min under a vacuum; the reaction was stopped by adding 0.125 M glycine. Nuclei were isolated in an extraction buffer (1.7 M sucrose, 10 mM Tris-HCl, pH 8.0, 2 mM MgCl~2~, 0.15% Trion X-100, 5 mM β-mercaptoethanol, protease inhibitor cocktail (Roche)), and were re-suspended in a sonication buffer (50 mM Tris-HCl, pH 8.0, 10 mM EDTA, 1% SDS, protease inhibitor cocktail (Roche)). The chromatin was released by sonication and DNA fragments with an average size of 0.2--1.5 kb only were recovered. The extracted DNA fragments were diluted with an equal volume of ChIP dilution buffer (16.7 mM Trs-HCl, pH 8.0, 1.2 mM EDTA, 167 mM NaCl, 1.1% Triton X-100, protease inhibitor cocktail (Roche)) and incubated with polyclonal anti-RAV1 antibody (Ab Frontier) at 4°C overnight. The chromatin-antibody complex was precipitated with protein-A beads (GE Healthcare) at 4°C for 1 h. Reverse crosslinked DNA was captured and cleaned using the PCR cleanup kit (Favorgen Biotech Corp). PCR was performed using the specific primer sets indicated, and the fold change was normalized by the data from an experiment done using the same procedure without the antibody.

Primer sequences
----------------

Primer sequences for the genes used in this study are listed in [Supplementary Table S1](#s2-molce-41-12-1072){ref-type="supplementary-material"}.

RESULTS
=======

*RAV1*-overexpressing transgenic plants showed defective seed development
-------------------------------------------------------------------------

Previously, we reported that RAV1 is a negative regulator of growth ([@b6-molce-41-12-1072]), because overall growth retardation occurred in the *RAV1*-overexpressing transgenic plants compared with wild-type plants. The growth pattern of the *rav1* mutant appeared similar to that of wild-type plant showing a slight promotion only in the early stage of growth ([Supplementary Fig. S1](#s1-molce-41-12-1072){ref-type="supplementary-material"}). To further explore the specific functions of RAV1, we observed detailed morphological alterations of the *RAV1*-overexpressing transgenic plants. We frequently observed wrinkled and shrunken seeds in the *RAV1* -overexpressing plants, compared with the regularly ellipsoidal seed shape in wild-type plants. The frequency of the appearance of this aberrant seed shape was considerably higher in *RAV1*-overexpressing plants than in wild-type plants ([Fig. 1A](#f1-molce-41-12-1072){ref-type="fig"}). We further found that even normal shaped seeds from the *RAV1*-overexpressors were lighter and smaller than that of the wild-type plants ([Fig. 1B](#f1-molce-41-12-1072){ref-type="fig"}). These phenotypic alterations of seeds were not observed in the *rav1* mutant. Based on these results, we decided to further explore the effects of *RAV1* overexpression on the seed development and selected the *RAV1OE2* transgenic plant as a representative (hereafter *RAV1OE* ). In addition to the abnormal seeds that were already harvested, we found that the silique shape of the transgenic plants was different from that of wild-type plants. Unlike the long and flat cylindrical siliques in wild-type plants, short and sunken siliques with empty space were observed in the *RAV1*-overexpressors. Green siliques of the *RAV1*-overexpressing plants contained several brown-colored ovules and aborted ovules ([Fig. 1C](#f1-molce-41-12-1072){ref-type="fig"}). The brown-colored ovules are un-fertilized ovules, and the withering aborted whitish ovules results from ovule development failure ([@b16-molce-41-12-1072]). To analyze the results quantitatively, we separately counted the numbers of normal-looking seeds, unfertilized ovules, and aborted ovules in each silique. Less than 1% of seeds showed defective development of approximately 40 seeds in the wild-type silique. In contrast, more than 45% of developing seeds of the total of approximately 20 seeds in a silique of *RAV1*-overexpressing plants were defective, and degenerating seed development was detected ([Fig. 1D](#f1-molce-41-12-1072){ref-type="fig"}). This phenomenon was likely to be specific to RAV1's action, because similar defective phenotypes did not occur in the *rav1l* or *rav2* mutant and in the transgenic plants overexpressing *RAV1L* or *RAV2* ([Supplementary Fig. S2](#s1-molce-41-12-1072){ref-type="supplementary-material"}).

Next, we investigated whether the seeds from *RAV1*-overexpressing plants had any defects in germination after maturation. Because considerable proportions (approximately 5%) of the final seed shape was aberrant in the *RAV1*-overexpressing plants ([Fig. 1A](#f1-molce-41-12-1072){ref-type="fig"}), we performed the germination test separately for the normal-looking seeds (NS) and aberrant-looking seeds (AS). Under normal conditions, wild-type seeds germinated almost completely at 2 days after imbibition (DAI). Although NS from the *RAV1*-overexpressing plants showed a germination rate similar to that of the wild type, it was slightly lower at 2 DAI than that of wild-type seeds. In contrast, AS from the *RAV1* -overexpressing plants showed a significantly reduced germination rate; only 40% of seeds had germinated at 2 DAI, and more than 20% of the seeds did not germinate even after 5 DAI ([Fig. 2](#f2-molce-41-12-1072){ref-type="fig"}). These results suggest that seed germination was delayed, and seed viability was reduced in the AS of the *RAV1*-overexpressing plants.

Natural expression of *RAV1* kept low in the early stage of seed development
----------------------------------------------------------------------------

Because normal seed development was perturbed in the *RAV1*-overexpressing transgenic plants as shown above, we thought that it would be important to first know how natural expression of the endogenous *RAV1* changes during seed development. To address this issue, we isolated RNA from different stages of developing flowers and siliques from fertilization to seed maturation stages, which were determined based on flower morphology ([@b26-molce-41-12-1072]). Flower organ development was almost complete at stage 12. Then, complete anthesis and fertilization occurred successively at stage 13, and developing siliques elongated through stage 15, and petals and sepals were withered at stage 16. All floral organs fell off from green siliques, and siliques became more elongated and yellow during stages 17--20 ([Fig. 3A](#f3-molce-41-12-1072){ref-type="fig"}). Using the RNAs of each stage, we performed quantitative real time-polymerase chain reaction (qRT-PCR) analyses for *RAV1* expression. Whereas *RAV1* expression remarkably increased up to 60-fold at stage 18 when the green siliques became distinct, *RAV1* expression did not considerably change during stage 12 to 16, during which the early stage of seed development occurred ([Fig. 3B](#f3-molce-41-12-1072){ref-type="fig"}). This result suggests that *RAV1* expression at low levels during the early stage of seed development is required for proper seed development. Excessive expression of *RAV1* caused by ectopic overexpression, such as in the *RAV1*-overexpressing plants, inhibits normal seed development.

The expressions of *MINI3* and *IKU2*, which are involved in endosperm and embryo development, were reduced in the *RAV1*-overexpressing plants
-----------------------------------------------------------------------------------------------------------------------------------------------

As endogenous expression of the *RAV1* was low at stages 12--16 during seed development (as shown above ([Fig. 3B](#f3-molce-41-12-1072){ref-type="fig"}), it is reasonable to assume that the overexpression of *RAV1* can interfere with timely expression of the genes involved in proper seed development. Therefore, we next focused on identifying the genes affected by *RAV1* overexpression during these stages.

Among many genes, the *SHB1, MINI3, and IKU2* were good candidates to test, because the *SHB1*-*MINI3*-*IKU2* pathway is a well-known cascade for the positive regulation of endosperm proliferation and embryo development. SHB1 activates *MINI3* and *IKU2* expression and MINI3 activates *IKU2* ([@b20-molce-41-12-1072]). In addition, the ABA signaling component ABI5 negatively acts upstream of this pathway by directly binding to the promoter of *SHB1*, leading to its repression ([@b3-molce-41-12-1072]). Therefore, using the RNAs from stage 12 to 16, we compared the expressions of these genes in the wild type and *RAV1*-overexpressing plants. In wild-type plants, *SHB1* expression gradually decreased from stages 12 to 16 ([Fig. 4A](#f4-molce-41-12-1072){ref-type="fig"}), and *ABI5* expression changed with the opposite pattern of that of *SHB1,* especially at stages 12 and 13 ([Fig. 4B](#f4-molce-41-12-1072){ref-type="fig"}). Compared to these wild-type patterns, *SHB1* accumulation levels in *RAV1*-overexpressing plants were higher at all monitored stages, with the gradual reduction in expression delayed ([Fig. 4A](#f4-molce-41-12-1072){ref-type="fig"}). *ABI5* expression did not increase in *RAV1*-overexpressing plants at 13 stage ([Fig. 4B](#f4-molce-41-12-1072){ref-type="fig"}). These results suggest that *ABI5* expression was repressed by the overexpression of *RAV1*, resulting in the increased expression of *SHB1* in the *RAV1*-overexpressing plants. Next, we compared expression of the *MINI3* and *IKU2*. In wild-type plants, both *MINI3* and *IKU2* expression increased from stage 13 and remained continuously high until the stage 16, implying that SHB1 that was encoded by the previous activation of the *SHB1* transcript at stage 12, which caused the subsequent activation of these genes ([Figs. 4C and 4D](#f4-molce-41-12-1072){ref-type="fig"}). However, in the *RAV1*-overexpressing plants, despite the higher expression of *SHB1* at stage 12 and 13, the accumulations of *MINI3* and *IKU2* after stage 13 were much lower compared with those of wild-type plants ([Figs. 4C and 4D](#f4-molce-41-12-1072){ref-type="fig"}).

RAV1 directly binds to the promoter of *MINI3* and *IKU2*
---------------------------------------------------------

Because the expressions of *MINI3* and *IKU2* were not coupled with that of the expression of *SHB1* in the *RAV1*-overexpressing plants, we hypothesized that these genes could be the direct targets of RAV1. Indeed, the repression of *ABI5* by RAV1 was reported during seed germination and post-germination seedling growth. In addition to *ABI5*, RAV1 also directly binds to the promoters of *ABI3* and *ABI4*, leading to the perturbation of ABA signaling ([@b4-molce-41-12-1072]). Therefore, it is plausible that repression of *ABI5* by the RAV1 would be effective in seed development. To validate this hypothesis, we performed a chromatin immunoprecipitation (ChIP) assay. Immunoprecipitated chromatin samples against anti-RAV1 antibodies were prepared from the stage 15 and 16 flowers of *RAV1*-overexpressing plants. Then, the promoter regions of *ABI5* that were already reported to be the binding site for RAV1 in seedlings were targeted to be amplified. Compared with that of amplification results without antibody, we found that RI and RII fragments of the *ABI5* were significantly amplified in the samples containing the RAV1 antibody ([Supplementary Fig. S3](#s1-molce-41-12-1072){ref-type="supplementary-material"}).

In this study, we further focused on how RAV1 affects *MINI3* and *IKU2* expression. First, we analyzed the promoter sequences of *MINI3* and *IKU2* to determine whether any RAV1-binding motifs were present in these regions. RAV1 bound to two distinct DNA binding motifs, 5′-CAACA-3′ and 5′-CACCTG-3′ ([@b13-molce-41-12-1072]). The latter is similar to the E-box (CANNTG) motif. We found two 5′-CAACA-3′ motifs and six E-box-like 5′-CACCTG-3′ motifs within the 1 Kb region of the *MINI3* promoter, and seven 5′-CAACA-3′ motifs and five 5′-CACCTG-3′ motifs in the 1 Kb region of the *IKU2* promoter ([Figs. 5A and 5B](#f5-molce-41-12-1072){ref-type="fig"}). To confirm whether these motifs could be the actual target sites for RAV1, we performed a ChIP assay with the same immunoprecipitated chromatin samples against anti-RAV1 antibodies that were used for *ABI5*. We determined that several fragments containing the RAV1-binding motifs in the promoters of *MINI3* and *IKU2* were amplified. We found that the RI fragment contained one 5′-CAACA-3′ motif, spanning from −368 to −521 bases in the promoter of *MINI3*, and it was approximately two-fold more amplified than that of the negative control ([Fig. 5A](#f5-molce-41-12-1072){ref-type="fig"}). In the promoter of *IKU2*, the RII fragment spanning from −543 to −646 bases was significantly amplified ([Fig. 5B](#f5-molce-41-12-1072){ref-type="fig"}). Taken together, our findings suggest that the reduced expression of *MINI3* and *IKU2* in addition to *ABI5* in the *RAV1*-overexpressing plants was caused by direct binding of the RAV1 to their promoters, resulting in their repression.

Defective seed development of *RAV1*-overexpressing plants was partially rescued by BL treatment
------------------------------------------------------------------------------------------------

BRs promote seed development ([@b12-molce-41-12-1072]) and repress *RAV1* expression ([@b10-molce-41-12-1072]). *RAV1* expression decreased naturally during seed development ([Fig. 2](#f2-molce-41-12-1072){ref-type="fig"}). If the overexpression of *RAV1* conferred inhibitory effects on seed development, direct application of BR may promote seed development of the *RAV1*-overexpressing plants. To prove this hypothesis, we treated brassinolide (BL), the most bioactive BR, to the floral buds at stage 12--13, just before seed development commenced. We also examined the effect of ABA on seed development for comparison. After 7 days, we collected elongated siliques and observed the seeds inside them. In the wild-type silique, most of the seeds were normal. We found that ABA treatment in the wild-type flower severely inhibited seed development thereafter, whereas BL treatment did not much alter the proportion of normally developed seeds compared with that of the mock-treatment ([Fig. 6A](#f6-molce-41-12-1072){ref-type="fig"}). In comparison, more than half of the seeds were defective or non-fertile ovules in the siliques of the *RAV1*-overexpressing plants. Interestingly, we observed that BL treatment improved normal seed development approximately 15% ([Fig. 6B](#f6-molce-41-12-1072){ref-type="fig"}). ABA significantly inhibited normal seed development in *RAV1*-overexpressing plants, as well as in wild-type plants.

DISCUSSION
==========

Successful seed development depends on several criteria, such as seed size/mass, seed number per silique, and proper seed shape ([@b12-molce-41-12-1072]). In this study, we showed that overexpression of *RAV1* adversely affected all aspects of seed development: reduced seed size and mass, decreased seed numbers in a silique, and aberrant seed shape ([Fig. 1](#f1-molce-41-12-1072){ref-type="fig"}). Previously, *RAV1* was reported to be one of the representative genes that was down-regulated by BR ([@b10-molce-41-12-1072]). Recently, *RAV1* was also shown to be down-regulated by ABA ([@b6-molce-41-12-1072]).

During seed development, two peaks in ABA accumulation have been noted. First, ABA accumulation originates from the maternal tissues and promotes endosperm development. Later, another ABA peak occurs in the embryo during the late maturation stage up to desiccation ([@b5-molce-41-12-1072]), which is the more profound function of ABA during seed development. ABA-deficient mutants, such as *aba2-1*, *aba1*, and *nced6* exhibit increased seed size because of delayed endosperm cellularization, although their silique length was shorter than that of the wild type ([@b3-molce-41-12-1072]). The timing of endosperm cellularization is important to the determination of the final seed size ([@b14-molce-41-12-1072]; [@b28-molce-41-12-1072]). Indeed, precocious cellularization of the endosperm causes reduced nuclear proliferation, resulting in smaller seed size; in contrast, delayed cellularization leads to increased seed size ([@b8-molce-41-12-1072]; [@b7-molce-41-12-1072]; [@b20-molce-41-12-1072]). In *aba2-1* mutants, the upregulation of *SHB1* expression was repressed by the application of ABA ([@b3-molce-41-12-1072]). ABI5 directly binds to the promoter region of *SHB1*, leading to its repression. This might trigger the subsequent embryo development. This notion is consistent with our observation that endogenous expression of *ABI5* and *SHB1* was oppositely regulated in flowers at stages 12 and 13, and *SHB1* expression gradually decreased in flowers from stage 13 to 16 ([Figs. 4A and 4B](#f4-molce-41-12-1072){ref-type="fig"}). *ABI5* was shown to be a direct target of RAV1 during seedling development ([@b4-molce-41-12-1072]) and seed maturation ([Supplementary Fig. S3](#s1-molce-41-12-1072){ref-type="supplementary-material"}). In the presence of ABA, RAV1 was phosphorylated by SnRK2 kinases ([@b4-molce-41-12-1072]), which are the positive regulators of ABA signaling ([@b20-molce-41-12-1072]; [@b21-molce-41-12-1072]; [@b36-molce-41-12-1072]). Phosphorylated RAV1 lost its ability to repress *ABI5* expression ([@b4-molce-41-12-1072]). Previously, we and another group reported that *RAV1*-overexpressing plants exhibited ABA insensitivity ([@b4-molce-41-12-1072]; [@b6-molce-41-12-1072]). Therefore, the timely expression of *ABI5* and *SHB1* was deregulated in the *RAV1*-overexpressing plants ([Figs. 4A and 4B](#f4-molce-41-12-1072){ref-type="fig"}). In addition, the higher *SHB1* expression in these plants did not couple with increased expression of *MINI3* and *IKU2* ([Figs. 4C and 4D](#f4-molce-41-12-1072){ref-type="fig"}).

Recently, reduced seed cavity and endosperm volume in the BR-deficient mutant *det2* was shown to result in delayed embryo development and decreased embryo size and number ([@b12-molce-41-12-1072]). The fact that BR treatment rescued the defects of *det2* implied that the activation of BR signaling is required for normal seed development. *SHB1*, *IKU1*, *MINI3,* and *IKU2* are genes induced by BR via BZR1 activity ([@b12-molce-41-12-1072]). BR-induced repression of *RAV1* seems to be mediated by the direct binding of BZR1 to the promoter of *RAV1* ([@b10-molce-41-12-1072]; [@b29-molce-41-12-1072]). These findings correlate well with our result that endogenous *RAV1* expression was maintained at a low level during early seed development stages ([Fig. 3B](#f3-molce-41-12-1072){ref-type="fig"}). Furthermore, we showed that *RAV1* overexpression decreased the expression of *MINI3* and *IKU2* ([Figs. 4C and 4D](#f4-molce-41-12-1072){ref-type="fig"}) by directly binding to their promoters ([Figs. 5A and 5B](#f5-molce-41-12-1072){ref-type="fig"}). *IKU2* encodes a leucine-rich repeat kinase and probably transduces important signaling for endosperm and embryo development ([@b20-molce-41-12-1072]). These results suggest that the overexpression of *RAV1* counteracts BZR1 in the activation of *MINI3* and then *IKU2* expression ([Fig. 6C](#f6-molce-41-12-1072){ref-type="fig"}). The results showing that direct treatment with BL improved normal seed development in the *RAV1*-overexpressing plants also supported this model ([Fig. 6B](#f6-molce-41-12-1072){ref-type="fig"}). Under natural conditions, gradients of plant hormones accumulate in different seed compartments during seed development ([@b19-molce-41-12-1072]). Therefore, the accumulation of plant hormones and transcriptional activity of RAV1 might coordinately regulate the expression of the core components for endosperm and embryo development.
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![Defective seed development in the *RAV1*-overexpressing transgenic plants\
(A) Frequency of aberrant seeds in *rav1* mutant and the *RAV1*-overexpressing plants compared with those in the wild-type plant (n = 300 seeds per each plant). Seed shape of the *RAV1OE2* transgenic plant is shown compared with that of the wild-type plant. Scale bars indicate 1 mm. (B) Seed weight of *rav1* mutant and the *RAV1*-overxpressing plants compared with that of wild-type plants. Values labeled with different letters in (A) and (B) indicate statistical differences across each plant line by one-way ANOVA (*P* \< 0.05). (C) Shape of a silique and the seeds within it of the *RAV1*-overexpressing plants compared with those of wild-type plants. Un-fertilized ovules and aborted whitish ovules are marked with white arrow and red arrowhead, respectively. Scale bars indicate 1 mm. (D) Frequency of the various seeds in a silique of the *RAV1*-overexpressing plants compared with those in wild-type plants (n = 15 siliques in each plant, \**P* \< 0.001 for all kinds of seeds).](molce-41-12-1072f1){#f1-molce-41-12-1072}

![Defective seed development continues to adversely affect seed germination\
Comparison of seed germination of the normal-looking (NS) and aberrant-looking (AS) seeds from the *RAV1*-overexpressing plants with those from wild-type plants. Values labeled with different letters in 2 or 3 DAI indicate a statistical difference across each day by one-way ANOVA (*P* \< 0.05).](molce-41-12-1072f2){#f2-molce-41-12-1072}

![Expression analyses of RAV1 during seed development\
(A) Picture of developing flower and siliques of a wild-type plant from which RNA was isolated. Scale bar indicates 10 mm. (B) Relative expression of *RAV1* determined using qRT-PCR analysis during indicated flower stages. Inset denotes the expression of *RAV1* from stages 12 to 16. qRT-PCR was conducted in triplicate in each experiment and data were normalized to the expression of *Ubiquitin*. Experiments were independently repeated twice. Error bars indicate standard error.](molce-41-12-1072f3){#f3-molce-41-12-1072}

![Expression analyses of the genes associated with embryo and endosperm development\
Expressions level of *SHB1* (A), *ABI5* (B), *MINI3* (C), and *IKU2* (D) were analyzed during the period indicated as the flower stage of the *RAV1*-overexpressing plants compared with those of wild-type plants. In each experiment, RNAs were examined in triplicate in each experiment and data were normalized to the expression of *Ubiquitin*. Experiments were independently repeated three times. Error bars indicate standard error. (\**P* \< 0.01 compared with wild-type plant at the same floral stage)](molce-41-12-1072f4){#f4-molce-41-12-1072}

![RAV1 directly binds to the promoter of *MIN3* and *IKU2*\
A and B. Two different RAV1-binding sites are marked with red and blue bars in a schematic representation of the *MINI3* and *IKU2* promoters, respectively (upper panels). Graph showing the relative amplification of the fragments containing RAV1-binding sites of *MINI3* or *IKU2* using ChIP analyses (lower panels). (\**P* \< 0.05 compared with the same amplified region without antibody treatment)](molce-41-12-1072f5){#f5-molce-41-12-1072}

![RAV1 interacts with BR and ABA signaling\
Treatment with BL or ABA of the floral bud of wild-type (A) and *RAV1*-overexpressing transgenic plant (B) affects seed development. After hormone treatment, frequency of the various seeds in a silique from each plant were counted and compared with those from mock-treated plants (n = 15 siliques from each plant, \**p* \< 0.001 compared with mock-treated sample). C. Model for RAV1 action in seed development. The SHB1-MINI3-IKU2 pathway is positively regulated by BR via the action of BZR1 and is negatively regulated by ABA via the action of ABI5. In this known pathway, RAV1, whose transcriptional expression is down-regulated by BZR1, represses the expression of *ABI5*, *MINI3,* and *IKU2* as a transcriptional repressor, which provides information for the fine regulation of seed development.](molce-41-12-1072f6){#f6-molce-41-12-1072}
